Skip to main content

01.01.2007 | Original Article

Laparoscopic versus open approach for solitary insulinoma

verfasst von: Antonio Sa Cunha, Cedric Beau, Alexandre Rault, Bogdan Catargi, Denis Collet, Bernard Masson

Erschienen in: Surgical Endoscopy | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

In recent years, advances in laparoscopic techniques have allowed surgeons to treat pancreatic lesions laparoscopically. Insulinoma, the most prevalent pancreatic endocrine tumor, is mostly benign and curable with surgical resection. This study aimed to assess the results from laparoscopic resection (LG) of insulinomas and to compare them with the results from open surgery (OG).

Methods

From September 1999 to December 2005, 56 laparoscopic pancreatic resections were performed for selected patients, including 12 laparoscopic resections of insulinomas. The results were compared with those of patients who underwent open resection of insulinomas selected from the authors’ pancreatic database.

Results

Three conversions to the open approach were required because of inability to identify the tumor. There were no deaths in either group, and the morbidity rates were 25% (3/12) for LG and 55% (5/9) for OG (nonsignificant difference). The pancreatic fistula rate after laparoscopic enucleation was statistically lower than after open enucleation (14% vs 100%; p = 0.015). The mean postoperative hospital stay was 13 ± 5.9 days for LG and 17.6 ± 7.5 days for OG (nonsignificant difference). After exclusion of the patients who underwent conversion to laparotomy, the mean postoperative hospital stay was 11.5 ± 5.8 days for LG and 17.6 ± 7.5 days for OG (p = 0.04).

Conclusion

This study demonstrates the feasibility and safety of laparoscopic resection of insulinomas. The laparoscopic approach was associated with a decrease in hospital stay and pancreatic fistula after enucleation. Preoperative localization tests and laparoscopic ultrasonography seem necessary to prevent conversion.
Literatur
1.
Zurück zum Zitat Catarci M, Gentileschi P, Papi C, Carrara A, Marrese R, Gaspari AL, et al. (2004) Evidence-based appraisal of antireflux fundoplication. Ann Surg 239(3): 325–37PubMedCrossRef Catarci M, Gentileschi P, Papi C, Carrara A, Marrese R, Gaspari AL, et al. (2004) Evidence-based appraisal of antireflux fundoplication. Ann Surg 239(3): 325–37PubMedCrossRef
2.
Zurück zum Zitat Senagore AJ (2005) Laparoscopic sigmoid colectomy for diverticular disease. Surg Clin North Am 85(1): 19–24, viiPubMedCrossRef Senagore AJ (2005) Laparoscopic sigmoid colectomy for diverticular disease. Surg Clin North Am 85(1): 19–24, viiPubMedCrossRef
3.
Zurück zum Zitat Khaitan L, Holzman MD (2002) Laparoscopic advances in general surgery. Jama 287(12): 1502–5PubMedCrossRef Khaitan L, Holzman MD (2002) Laparoscopic advances in general surgery. Jama 287(12): 1502–5PubMedCrossRef
4.
Zurück zum Zitat Masson B, Sa-Cunha A, Laurent C, Rault A, Collet D (2003) [Laparoscopic pancreatectomy:report of 22 cases]. Ann Chir 128(7): 452–6PubMedCrossRef Masson B, Sa-Cunha A, Laurent C, Rault A, Collet D (2003) [Laparoscopic pancreatectomy:report of 22 cases]. Ann Chir 128(7): 452–6PubMedCrossRef
5.
Zurück zum Zitat Gagner M, Inabnet WB, Biertho L, Salky B (2004) [Laparoscopic pancreatectomy: a series of 22 patients]. Ann Chir 129(1): 2–7; discussion 8–10PubMedCrossRef Gagner M, Inabnet WB, Biertho L, Salky B (2004) [Laparoscopic pancreatectomy: a series of 22 patients]. Ann Chir 129(1): 2–7; discussion 8–10PubMedCrossRef
6.
Zurück zum Zitat Fernandez-Cruz L, Saenz A, Astudillo E, Martinez I, Hoyos S, Pantoja JP, et al. (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 26(8): 1057–65PubMedCrossRef Fernandez-Cruz L, Saenz A, Astudillo E, Martinez I, Hoyos S, Pantoja JP, et al. (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 26(8): 1057–65PubMedCrossRef
7.
Zurück zum Zitat Edwin B, Mala T, Mathisen O, Gladhaug I, Buanes T, Lunde OC, et al. (2004) Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc 18(3): 407–11PubMedCrossRef Edwin B, Mala T, Mathisen O, Gladhaug I, Buanes T, Lunde OC, et al. (2004) Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc 18(3): 407–11PubMedCrossRef
8.
Zurück zum Zitat Shimizu S, Tanaka M, Konomi H, Mizumoto K, Yamaguchi K (2004) Laparoscopic pancreatic surgery: current indications and surgical results. Surg Endosc 18(3): 402–6PubMedCrossRef Shimizu S, Tanaka M, Konomi H, Mizumoto K, Yamaguchi K (2004) Laparoscopic pancreatic surgery: current indications and surgical results. Surg Endosc 18(3): 402–6PubMedCrossRef
9.
Zurück zum Zitat Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J, et al. (2005) Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 137(6): 597–605PubMedCrossRef Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J, et al. (2005) Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 137(6): 597–605PubMedCrossRef
10.
Zurück zum Zitat Park AE, Heniford BT (2002) Therapeutic laparoscopy of the pancreas. Ann Surg 236(2): 149–58PubMedCrossRef Park AE, Heniford BT (2002) Therapeutic laparoscopy of the pancreas. Ann Surg 236(2): 149–58PubMedCrossRef
11.
Zurück zum Zitat Service FJ, McMahon MM, O’Brien PC, Ballard DJ (1991) Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7): 711–9PubMed Service FJ, McMahon MM, O’Brien PC, Ballard DJ (1991) Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7): 711–9PubMed
12.
Zurück zum Zitat Finlayson E, Clark OH (2004) Surgical treatment of insulinomas. Surg Clin North Am 84(3): 775–85PubMedCrossRef Finlayson E, Clark OH (2004) Surgical treatment of insulinomas. Surg Clin North Am 84(3): 775–85PubMedCrossRef
13.
Zurück zum Zitat Assalia A, Gagner M (2004) Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. World J Surg 28(12): 1239–47PubMedCrossRef Assalia A, Gagner M (2004) Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. World J Surg 28(12): 1239–47PubMedCrossRef
14.
Zurück zum Zitat Ayav A, Bresler L, Brunaud L, Boissel P (2005) Laparoscopic approach for solitary insulinoma: a multicentre study. Langenbecks Arch Surg 390(2): 134–40PubMedCrossRef Ayav A, Bresler L, Brunaud L, Boissel P (2005) Laparoscopic approach for solitary insulinoma: a multicentre study. Langenbecks Arch Surg 390(2): 134–40PubMedCrossRef
15.
Zurück zum Zitat Fernandez-Cruz L, Martinez I, Cesar-Borges G, Astudillo E, Orduna D, Halperin I, et al. (2005) Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1. J Gastrointest Surg 9(3): 381–8PubMedCrossRef Fernandez-Cruz L, Martinez I, Cesar-Borges G, Astudillo E, Orduna D, Halperin I, et al. (2005) Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1. J Gastrointest Surg 9(3): 381–8PubMedCrossRef
16.
Zurück zum Zitat Berends FJ, Cuesta MA, Kazemier G, van Eijck CH, de Herder WW, van Muiswinkel JM, et al. (2000) Laparoscopic detection and resection of insulinomas. Surgery 128(3): 386–91PubMedCrossRef Berends FJ, Cuesta MA, Kazemier G, van Eijck CH, de Herder WW, van Muiswinkel JM, et al. (2000) Laparoscopic detection and resection of insulinomas. Surgery 128(3): 386–91PubMedCrossRef
17.
Zurück zum Zitat Jaroszewski DE, Schlinkert RT, Thompson GB, Schlinkert DK (2004) Laparoscopic localization and resection of insulinomas. Arch Surg 139(3): 270–4PubMedCrossRef Jaroszewski DE, Schlinkert RT, Thompson GB, Schlinkert DK (2004) Laparoscopic localization and resection of insulinomas. Arch Surg 139(3): 270–4PubMedCrossRef
18.
Zurück zum Zitat Gagner M, Pomp A, Herrera MF (1996) Early experience with laparoscopic resections of islet cell tumors. Surgery 120(6): 1051–4PubMedCrossRef Gagner M, Pomp A, Herrera MF (1996) Early experience with laparoscopic resections of islet cell tumors. Surgery 120(6): 1051–4PubMedCrossRef
19.
Zurück zum Zitat Lo CY, Chan WF, Lo CM, Fan ST, Tam PK (2004) Surgical treatment of pancreatic insulinomas in the era of laparoscopy. Surg Endosc 18(2): 297–302PubMedCrossRef Lo CY, Chan WF, Lo CM, Fan ST, Tam PK (2004) Surgical treatment of pancreatic insulinomas in the era of laparoscopy. Surg Endosc 18(2): 297–302PubMedCrossRef
20.
Zurück zum Zitat Warshaw AL (1988) Conservation of the spleen with distal pancreatectomy. Arch Surg 123(5): 550–3PubMed Warshaw AL (1988) Conservation of the spleen with distal pancreatectomy. Arch Surg 123(5): 550–3PubMed
21.
Zurück zum Zitat Lesurtel M, Cherqui D, Laurent A, Tayar C, Fagniez PL (2003) Laparoscopic versus open left lateral hepatic lobectomy: a case-control study. J Am Coll Surg 196(2): 236–42PubMedCrossRef Lesurtel M, Cherqui D, Laurent A, Tayar C, Fagniez PL (2003) Laparoscopic versus open left lateral hepatic lobectomy: a case-control study. J Am Coll Surg 196(2): 236–42PubMedCrossRef
22.
Zurück zum Zitat Rullier E, Sa Cunha A, Couderc P, Rullier A, Gontier R, Saric J (2003) Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg 90(4): 445–51PubMedCrossRef Rullier E, Sa Cunha A, Couderc P, Rullier A, Gontier R, Saric J (2003) Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg 90(4): 445–51PubMedCrossRef
23.
Zurück zum Zitat Clinical Outcomes of Surgical Therapy Study Group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350(20): 2050–9CrossRef Clinical Outcomes of Surgical Therapy Study Group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350(20): 2050–9CrossRef
24.
Zurück zum Zitat Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, et al. (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 359(9325): 2224–9PubMedCrossRef Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, et al. (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 359(9325): 2224–9PubMedCrossRef
25.
Zurück zum Zitat Rothmund M, Angelini L, Brunt LM, Farndon JR, Geelhoed G, Grama D, et al. (1990) Surgery for benign insulinoma: an international review. World J Surg 14(3): 393–8; discussion 398–9PubMedCrossRef Rothmund M, Angelini L, Brunt LM, Farndon JR, Geelhoed G, Grama D, et al. (1990) Surgery for benign insulinoma: an international review. World J Surg 14(3): 393–8; discussion 398–9PubMedCrossRef
26.
Zurück zum Zitat Mabrut JY, Lifante JC, Cherki S, Sin S, Berger N, Peix JL (2001) [Is preoperative localization of insulinomas necessary?]. Ann Chir 126(9): 850–6PubMedCrossRef Mabrut JY, Lifante JC, Cherki S, Sin S, Berger N, Peix JL (2001) [Is preoperative localization of insulinomas necessary?]. Ann Chir 126(9): 850–6PubMedCrossRef
27.
Zurück zum Zitat Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST (1997) Pancreatic insulinomas. A 15-year experience. Arch Surg 132(8): 926–30 Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST (1997) Pancreatic insulinomas. A 15-year experience. Arch Surg 132(8): 926–30
28.
Zurück zum Zitat Knaebel HP, Diener MK, Wente MN, Buchler MW, Seiler CM (2005) Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg 92(5): 539–46PubMedCrossRef Knaebel HP, Diener MK, Wente MN, Buchler MW, Seiler CM (2005) Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg 92(5): 539–46PubMedCrossRef
29.
Zurück zum Zitat Buchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, et al. (1992) Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163(1): 125–30; discussion 130–1PubMedCrossRef Buchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, et al. (1992) Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163(1): 125–30; discussion 130–1PubMedCrossRef
30.
Zurück zum Zitat Friess H, Beger HG, Sulkowski U, Becker H, Hofbauer B, Dennler HJ, et al. (1995) Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82(9): 1270–3PubMed Friess H, Beger HG, Sulkowski U, Becker H, Hofbauer B, Dennler HJ, et al. (1995) Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82(9): 1270–3PubMed
31.
Zurück zum Zitat Gouillat C, Chipponi J, Baulieux J, Partensky C, Saric J, Gayet B (2001) Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg 88(11): 1456–62PubMedCrossRef Gouillat C, Chipponi J, Baulieux J, Partensky C, Saric J, Gayet B (2001) Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg 88(11): 1456–62PubMedCrossRef
32.
Zurück zum Zitat Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, et al. (1997) Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226(5): 632–41PubMedCrossRef Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, et al. (1997) Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226(5): 632–41PubMedCrossRef
33.
Zurück zum Zitat Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, et al. (1995) Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117(1): 26–31PubMedCrossRef Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, et al. (1995) Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117(1): 26–31PubMedCrossRef
34.
Zurück zum Zitat Pederzoli P, Bassi C, Falconi M, Camboni MG (1994) Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 81(2): 265–9 Pederzoli P, Bassi C, Falconi M, Camboni MG (1994) Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 81(2): 265–9
35.
Zurück zum Zitat Sarr MG (2003) The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196(4): 556–64; discussion 564–5; author reply 565PubMedCrossRef Sarr MG (2003) The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196(4): 556–64; discussion 564–5; author reply 565PubMedCrossRef
36.
Zurück zum Zitat Shan YS, Sy ED, Lin PW (2003) Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 27(6): 709–14PubMedCrossRef Shan YS, Sy ED, Lin PW (2003) Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 27(6): 709–14PubMedCrossRef
37.
Zurück zum Zitat Suc B, Msika S, Piccinini M, Fourtanier G, Hay JM, Flamant Y, et al. (2004) Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg 139(3): 288–94; discussion 295PubMedCrossRef Suc B, Msika S, Piccinini M, Fourtanier G, Hay JM, Flamant Y, et al. (2004) Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg 139(3): 288–94; discussion 295PubMedCrossRef
38.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. (2000) Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232(3): 419–29PubMedCrossRef Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. (2000) Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232(3): 419–29PubMedCrossRef
39.
Zurück zum Zitat Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ (2005) Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 92(9): 1059–67PubMedCrossRef Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ (2005) Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 92(9): 1059–67PubMedCrossRef
40.
Zurück zum Zitat Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA (2001) Intraoperative ultrasound and preoperative localization detects all occult insulinomas; discussion 1025–6. Arch Surg 136(9): 1020–5PubMedCrossRef Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA (2001) Intraoperative ultrasound and preoperative localization detects all occult insulinomas; discussion 1025–6. Arch Surg 136(9): 1020–5PubMedCrossRef
41.
Zurück zum Zitat Hashimoto LA, Walsh RM (1999) Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189(4): 368–73PubMedCrossRef Hashimoto LA, Walsh RM (1999) Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189(4): 368–73PubMedCrossRef
42.
Zurück zum Zitat Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, et al. (2003) CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 181(4): 987–92PubMed Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, et al. (2003) CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 181(4): 987–92PubMed
43.
Zurück zum Zitat Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB (2000) Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 214(2): 483–90PubMed Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB (2000) Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 214(2): 483–90PubMed
Metadaten
Titel
Laparoscopic versus open approach for solitary insulinoma
verfasst von
Antonio Sa Cunha
Cedric Beau
Alexandre Rault
Bogdan Catargi
Denis Collet
Bernard Masson
Publikationsdatum
01.01.2007
Erschienen in
Surgical Endoscopy / Ausgabe 1/2007
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-006-0021-8

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.